Literature DB >> 10473519

Immune response of children who develop persistent diarrhea following rotavirus infection.

T Azim1, S M Ahmad, M S Sarker, L E Unicomb, S De, J D Hamadani, M A Salam, M A Wahed, M J Albert.   

Abstract

A prospective study was conducted with Bangladeshi children with rotavirus (RV) diarrhea to assess whether nutritional and clinical parameters, RV serotypes, levels of interleukin-10 (IL-10), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma), and RV-specific antibody titers in plasma and stool were associated with the development of persistent diarrhea. Children with watery diarrhea for 6 to 8 days, selected from the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), were enrolled in the study and monitored until diarrhea improved. Children were classified as having acute diarrhea (AD) if diarrhea resolved within 14 days of onset and as having persistent diarrhea (PD) if diarrhea persisted for more than 14 days after onset. Uninfected, control children (n = 13) from the Nutrition Follow-Up Unit of ICDDR,B were also enrolled. Of the 149 children with diarrhea enrolled, 29 had diarrhea with RV alone, of which 19 had AD and 10 developed PD. Samples of stool and blood were collected from all children on enrollment. Stool samples were collected again from children when they developed PD. Of the 10 children who had an initial RV infection and then developed PD, only one had persistent RV infection. Plasma levels of IL-10 and TNF-alpha were higher in children with diarrhea compared to uninfected controls but were similar in children with AD and PD. Plasma IFN-gamma levels were higher in children who developed PD than in those with AD (P = 0.008) or uninfected controls (P = 0.001). In stools, the levels of TNF-alpha, the only cytokine detected, were similar in the three groups of children. RV-specific immunoglobulin G (IgG) titers in plasma were higher in uninfected children than in those with AD (P < 0.001) or PD (P = 0.024) but titers were similar in children with AD and PD. RV-specific IgA titers in plasma and stool were similar in the three groups of children. From all observed parameters, only elevated plasma IFN-gamma levels were associated with subsequent development of PD. However, a larger sample size is necessary to substantiate this observation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473519      PMCID: PMC95756          DOI: 10.1128/CDLI.6.5.690-695.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  33 in total

1.  Rotavirus infection and persistent diarrhoea in young children.

Authors:  V Khoshoo; M K Bhan; S Jayashree; R Kumar; R I Glass
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

2.  Delayed cutaneous hypersensitivity: epidemiologic factors affecting and usefulness in predicting diarrheal incidence in young Peruvian children.

Authors:  R E Black; C F Lanata; F Lazo
Journal:  Pediatr Infect Dis J       Date:  1989-04       Impact factor: 2.129

3.  Cellular immune competence and diarrheal morbidity in malnourished Bangladeshi children: a prospective field study.

Authors:  F T Koster; D L Palmer; J Chakraborty; T Jackson; G C Curlin
Journal:  Am J Clin Nutr       Date:  1987-07       Impact factor: 7.045

4.  Epidemiologic, clinical, and laboratory characteristics of acute vs. persistent diarrhea in periurban Lima, Peru.

Authors:  C F Lanata; R E Black; R H Gilman; F Lazo; R Del Aguila
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-01       Impact factor: 2.839

5.  Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus.

Authors:  R L Ward; D I Bernstein; R Shukla; E C Young; J R Sherwood; M M McNeal; M C Walker; G M Schiff
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

6.  Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans.

Authors:  M Yasukawa; O Nakagomi; Y Kobayashi
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

7.  Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.

Authors:  A Z Kapikian; R G Wyatt; M M Levine; R H Yolken; D H VanKirk; R Dolin; H B Greenberg; R M Chanock
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

8.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

9.  Chronic rotavirus infection in immunodeficiency.

Authors:  F T Saulsbury; J A Winkelstein; R H Yolken
Journal:  J Pediatr       Date:  1980-07       Impact factor: 4.406

10.  Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

Authors:  S Chiba; T Yokoyama; S Nakata; Y Morita; T Urasawa; K Taniguchi; S Urasawa; T Nakao
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

View more
  18 in total

1.  Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea.

Authors:  J Xu; Y Yang; J Sun; Y Ding; L Su; C Shao; B Jiang
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus.

Authors:  M S P Azevedo; L Yuan; S Pouly; A M Gonzales; K I Jeong; T V Nguyen; L J Saif
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems.

Authors:  Beth D Kirkpatrick; E Ross Colgate; Josyf C Mychaleckyj; Rashidul Haque; Dorothy M Dickson; Marya P Carmolli; Uma Nayak; Mami Taniuchi; Caitlin Naylor; Firdausi Qadri; Jennie Z Ma; Masud Alam; Mary Claire Walsh; Sean A Diehl; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2015-02-23       Impact factor: 2.345

4.  Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.

Authors:  Jennifer J Hull; Nigel Cunliffe; Khuzwayo C Jere; Sung-Sil Moon; Yuhuan Wang; Umesh Parashar; Baoming Jiang
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

5.  Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.

Authors:  Theresa Kathrina Resch; Yuhuan Wang; Sungsil Moon; Baoming Jiang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

6.  Cytokines as mediators for or effectors against rotavirus disease in children.

Authors:  B Jiang; L Snipes-Magaldi; P Dennehy; H Keyserling; R C Holman; J Bresee; J Gentsch; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

7.  Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.

Authors:  Kuldeep S Chattha; Anastasia N Vlasova; Sukumar Kandasamy; Gireesh Rajashekara; Linda J Saif
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

8.  The influence of CD4+ CD25+ Foxp3+ regulatory T cells on the immune response to rotavirus infection.

Authors:  Bumseok Kim; Ningguo Feng; Carlos F Narváez; Xiao-Song He; Seong Kug Eo; Chae Woong Lim; Harry B Greenberg
Journal:  Vaccine       Date:  2008-08-24       Impact factor: 3.641

9.  Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB.

Authors:  Gavan Holloway; Thanhmai T Truong; Barbara S Coulson
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

10.  Rotavirus antagonism of the innate immune response.

Authors:  Michelle M Arnold; John T Patton
Journal:  Viruses       Date:  2009-11-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.